Lipid-lowering agents and new onset diabetes mellitus

Long-Term Safety and Efficacy of Triple Combination Ezetimibe/Simvastatin Plus Extended-Release Niacin in Patients With Hyperlipidemia

(2009) Sergio Fazio et al.   AMERICAN JOURNAL OF CARDIOLOGY

Demographic Differences and Trends of Vitamin D Insufficiency in the US Population, 1988-2004

(2009) Adit A. Ginde et al.   ARCHIVES OF INTERNAL MEDICINE

Statin Therapy and Risk of Developing Type 2 Diabetes: A Meta-Analysis

(2009) S. N. Rajpathak et al.   DIABETES CARE

Differing effect of statins on insulin sensitivity in non-diabetics: A systematic review and meta-analysis

(2009) William L. Baker et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

The relative importance of modifiable potential risk factors of type 2 diabetes: a meta-analysis of two cohorts

(2009) Maarit A. Laaksonen et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Effects of Niacin on Glucose Control in Patients With Dyslipidemia

(2009) Ronald B. Goldberg et al.   MAYO CLINIC PROCEEDINGS

The Effect of Body Mass Index on Fasting Blood Glucose and Development of Diabetes Mellitus After Initiation of Extended-Release Niacin

(2009) Ardelle Libby et al.   Metabolic Syndrome and Related Disorders

Statin therapy, muscle function and vitamin D

(2009) M.R. Goldstein et al.   QJM-AN INTERNATIONAL JOURNAL OF MEDICINE

Comparison of the Safety and Efficacy of a Combination Tablet of Niacin Extended Release and Simvastatin vs Simvastatin Monotherapy in Patients With Increased Non–HDL Cholesterol (from the SEACOAST I Study)

(2008) Christie M. Ballantyne et al.   AMERICAN JOURNAL OF CARDIOLOGY

Differential metabolic effects of pravastatin and simvastatin in hypercholesterolemic patients

(2008) Kwang Kon Koh et al.   ATHEROSCLEROSIS

The effect of statins on the development of new-onset type 2 diabetes: a meta-analysis of randomized controlled trials

(2008) Craig I. Coleman et al.   CURRENT MEDICAL RESEARCH AND OPINION

Simvastatin Improves Flow-Mediated Dilation but Reduces Adiponectin Levels and Insulin Sensitivity in Hypercholesterolemic Patients

(2008) K. K. Koh et al.   DIABETES CARE

The HMG-CoA reductase inhibitor rosuvastatin and the angiotensin receptor antagonist candesartan attenuate atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes via effects on advanced glycation, oxidative stress and inflammation

(2008) A. C. Calkin et al.   DIABETOLOGIA

Baseline triglyceride levels and insulin sensitivity are major determinants of the increase of LDL particle size and buoyancy induced by rosuvastatin treatment in patients with primary hyperlipidemia

(2008) Michael S. Kostapanos et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Vascular risk factors in South Asians

(2008) Konstantinos Tziomalos et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

(2008) Paul M Ridker et al.   NEW ENGLAND JOURNAL OF MEDICINE

Low serum 25 (OH) vitamin D levels (

(2008) Waqas Ahmed et al.   Translational Research

Colesevelam improves glycemic control and lipid management in inadequately controlled type 2 diabetes mellitus

(2008) Konstantinos Tziomalos et al.   Nature clinical practice. Endocrinology & metabolism

Role of vitamin D in the pathogenesis of type 2 diabetes mellitus

(2007) X. Palomer et al.   DIABETES OBESITY & METABOLISM